Voyager Therapeutics, Inc. - VYGR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | President and CEO | S | D | 11,511.0 | 3.87 | 44,547.57 | 472,549.0 | View | |
| Apr 03, 2026 | SVP and General Counsel | A | A | 50,000.0 | 0.0 | 0.0 | 50,000.0 | View | |
| Feb 26, 2026 | Chief Financial Officer | S | D | 4,668.0 | 3.77 | 17,598.36 | 151,416.0 | View | |
| Feb 26, 2026 | President and CEO | S | D | 14,197.0 | 3.79 | 53,806.63 | 484,060.0 | View | |
| Feb 26, 2026 | COO & CBO | S | D | 6,458.0 | 3.77 | 24,346.66 | 199,738.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | S | D | 4,174.0 | 3.76 | 15,694.24 | 145,718.0 | View | |
| Feb 20, 2026 | Chief Scientific Officer | S | D | 3,301.0 | 3.44 | 11,355.44 | 149,892.0 | View | |
| Feb 20, 2026 | COO & CBO | S | D | 3,882.0 | 3.44 | 13,354.08 | 206,196.0 | View | |
| Feb 20, 2026 | President and CEO | S | D | 11,732.0 | 3.41 | 40,006.12 | 498,257.0 | View | |
| Feb 11, 2026 | COO & CBO | S | D | 4,569.0 | 3.85 | 17,590.65 | 210,078.0 | View | |
| Feb 11, 2026 | President and CEO | S | D | 12,192.0 | 3.78 | 46,085.76 | 509,989.0 | View | |
| Feb 11, 2026 | Chief Scientific Officer | S | D | 3,525.0 | 3.85 | 13,571.25 | 153,193.0 | View | |
| Feb 10, 2026 | President and CEO | A | A | 402,500.0 | 0.0 | 0.0 | 402,500.0 | View | |
| Feb 10, 2026 | President and CEO | A | A | 86,250.0 | 0.0 | 0.0 | 522,181.0 | View | |
| Feb 10, 2026 | COO & CBO | A | A | 210,000.0 | 0.0 | 0.0 | 210,000.0 | View | |
| Feb 10, 2026 | COO & CBO | A | A | 45,000.0 | 0.0 | 0.0 | 214,647.0 | View | |
| Feb 10, 2026 | Chief Scientific Officer | A | A | 154,000.0 | 0.0 | 0.0 | 154,000.0 | View | |
| Feb 10, 2026 | Chief Scientific Officer | A | A | 33,000.0 | 0.0 | 0.0 | 156,718.0 | View | |
| Feb 10, 2026 | Chief Medical Officer | A | A | 210,000.0 | 0.0 | 0.0 | 210,000.0 | View | |
| Feb 10, 2026 | Chief Medical Officer | A | A | 45,000.0 | 0.0 | 0.0 | 183,914.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | A | A | 150,500.0 | 0.0 | 0.0 | 150,500.0 | View | |
| Feb 10, 2026 | Chief Financial Officer | A | A | 32,250.0 | 0.0 | 0.0 | 156,084.0 | View | |
| Jan 08, 2026 | SVP and General Counsel | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View |